CYTOKINETICS INC — Director's Dealing 2024

Jun 3, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-05-31

Reporting Person: Lee Sung (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-31	Common Stock	A	34684	—	Acquired	34684	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-31	Non-Qualified Stock Option (Right to Buy)	$48.51	A	53417	Acquired	2034-05-30	Common Stock (53417)	Direct

Footnotes

F1: Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment.

F2: Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment.